CONMED (NASDAQ:CNMD) had its price target upped by Leerink Swann from $60.00 to $64.00 in a research note issued to investors on Tuesday.…
Read More »By Mark Watkins Research analysts at Northland Securities initiated coverage on shares of CONMED (NASDAQ:CNMD) in a report released on…
Read More »